Jul. 2 at 8:58 PM
$RFL How complex is this?
TRAPPSOL is an IV therapy administered once every two weeks. While very uncomfortable to receive over 8-12 hours, its negative side effects of dizziness and vomiting can be attenuated. We, therefore, have a drug superior to Adrabetadex.
Cyclo Therapeutics hinted at a potential problem, though, when they posted a single, anecdotal testimony from a patient who professed to feeling much better at, I’m guessing day 10? In any event besides not knowing how that patient felt on days 11, 12 and 13 prior to receiving their next treatment, we’re left to wonder how and with what frequency patients are being tested during the trial.
This isn’t arimoclomol or L-leucine which is taken every day, 3-times a day and whose effect likely remains constant from day to day over the course of therapy. Are patients being tested throughout the treatment cycle? On day 3 or 4 which would be optimal or on days 13 and 14? Is it random or controlled by the sponsor? Answers?
